Ms. Linda Sampson reports

MARAPHARM VENTURES INC. ANNOUNCES FOURTH TRANCHE OF SHARE PURCHASE WARRANT OFFERING

Marapharm Ventures Inc. has closed the fourth tranche of the private placement offering of up to 80 million common share purchase warrants at a price of 10 cents per warrant. The closing date was Jan. 15, 2018, with proceeds totalling $745,340 from the sale of 7,453,400 warrants.

Following the close of the four tranches, Marapharm has combined proceeds of $3,867,323 from the sale of 38,673,230 warrants. Final paperwork and regulatory filings are being completed for the remaining and final tranche which will close on Jan. 31, 2018.

About Marapharm Ventures Inc.

Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 it has rapidly expanded its footprint to include production locations in the key North American states of Washington, Nevada and California. It actively seeks expansion opportunities worldwide.

We seek Safe Harbor.